BUDESONIDE

Tillotts Pharma Ag🇨🇦 Health Canada

Approval Id: f3c968084a9c69cd
Drug Approval Canada Name: BUDESONIDE
Product Name: BUDESONIDE
Status: Dormant
Status Date: 2024-07-31
Original Market Date: 2020-01-17
Din: 02483874
Drug Class: Human
Dosage Form: Capsule (Sustained-Release)
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 68:04.00
Atc Original: A07EA06 BUDESONIDE
Atc Name: a 07 ea 06
Aig Number: 0116807006
Company Name: Tillotts Pharma Ag
Company Address: Warmbacher Strasse 80, Rheinfelden, Baden-Wuerttemberg, Germany, 79618
Company Detail Path: /organization/tillotts-pharma-ag

BUDESONIDE

3 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

f3c968084a9c69cd

Type

Standard